Biotricity(BTCY)
$0.05+0.00 (+3.92%)
BTCY
Biotricity financials statements
$0.05
At close:+0.00 (+3.92%)
Want to see BTCY full AI Analyst Report?
Biotricity (BTCY) Ratios
123 Followers
Biotricity Ratios
BTCY's free cash flow for Q1 2027 was $507.23K. For the 2027 fiscal year, BTCY's free cash flow was increased by $0.00 and operating cash flow was $507.23K. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Jun 25 | Mar 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.16 | 0.22 | 0.20 | 0.42 | 3.15 |
| Quick Ratio | 0.12 | 0.15 | 0.11 | 0.21 | 2.98 |
| Cash Ratio | 0.00 | 0.02 | 0.03 | 0.05 | 2.48 |
| Solvency Ratio | -0.04 | -0.24 | -0.39 | -0.71 | -1.55 |
| Operating Cash Flow Ratio | -0.02 | -0.12 | -0.29 | -1.21 | -3.12 |
| Short-Term Operating Cash Flow Coverage | -0.03 | -0.20 | -0.58 | -2.84 | -9.85 |
| Net Current Asset Value | $ -33.55M | $ -31.02M | $ -31.45M | $ -21.64M | $ -3.50M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 4.20 | 4.63 | 4.02 | 3.00 | 0.92 |
| Debt-to-Equity Ratio | -0.82 | -0.87 | -0.80 | -0.98 | -7.16 |
| Debt-to-Capital Ratio | -4.59 | -6.65 | -3.92 | -65.33 | 1.16 |
| Long-Term Debt-to-Capital Ratio | -0.03 | -0.78 | -0.57 | -1.92 | 1.21 |
| Financial Leverage Ratio | -0.20 | -0.19 | -0.20 | -0.33 | -7.78 |
| Debt Service Coverage Ratio | 0.11 | -0.19 | -0.53 | -2.18 | -1.53 |
| Interest Coverage Ratio | -0.50 | -0.47 | -1.70 | -5.97 | -1.58 |
| Debt to Market Cap | 4.20 | 3.44 | 1.75 | 0.74 | 0.14 |
| Interest Debt Per Share | 0.87 | 1.45 | 3.23 | 2.56 | 3.42 |
| Net Debt to EBITDA | 11.02 | -8.01 | -2.60 | -1.18 | -0.18 |
| Profitability Margins | |||||
| Gross Profit Margin | 80.94% | 76.61% | 69.27% | 56.46% | 59.74% |
| EBIT Margin | 10.57% | -23.34% | -73.80% | -166.77% | -242.62% |
| EBITDA Margin | 15.27% | -23.30% | -73.75% | -166.71% | -242.59% |
| Operating Profit Margin | 10.57% | -17.76% | -73.18% | -159.87% | -218.77% |
| Pretax Profit Margin | -15.03% | -61.07% | -116.84% | -193.57% | -380.78% |
| Net Profit Margin | -15.03% | -61.07% | -116.84% | -193.57% | -380.78% |
| Continuous Operations Profit Margin | -15.03% | -61.07% | -116.84% | -193.57% | -380.78% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | -142.15% | 343.87% | 159.65% | 121.08% | 174.05% |
| Return on Assets (ROA) | -37.29% | -149.29% | -237.17% | -286.58% | -174.66% |
| Return on Equity (ROE) | 7.29% | 28.06% | 47.02% | 94.02% | 1358.23% |
| Return on Capital Employed (ROCE) | -5.51% | 16.33% | 52.69% | 331.38% | -141.70% |
| Return on Invested Capital (ROIC) | -37.57% | 100.16% | 189.35% | -3351.02% | -123.41% |
| Return on Tangible Assets | -37.29% | -149.29% | -237.17% | -286.58% | -174.66% |
| Earnings Yield | -37.30% | -115.07% | -109.61% | -77.23% | -28.24% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.45 | 5.07 | 6.68 | 7.87 | 3.81 |
| Payables Turnover | 0.69 | 0.70 | 0.71 | 1.22 | 2.66 |
| Inventory Turnover | 2.27 | 2.07 | 1.97 | 1.80 | 3.65 |
| Fixed Asset Turnover | 45.73 | 16.78 | 9.75 | 5.99 | 6.02 |
| Asset Turnover | 2.48 | 2.44 | 2.03 | 1.48 | 0.46 |
| Working Capital Turnover Ratio | -0.68 | -0.81 | -0.98 | 4.80 | 3.57 |
| Cash Conversion Cycle | -299.50 | -272.80 | -274.50 | -49.15 | 58.23 |
| Days of Sales Outstanding | 66.91 | 71.96 | 54.62 | 46.35 | 95.74 |
| Days of Inventory Outstanding | 160.55 | 175.99 | 185.05 | 203.24 | 99.89 |
| Days of Payables Outstanding | 526.96 | 520.75 | 514.16 | 298.74 | 137.40 |
| Operating Cycle | 227.46 | 247.95 | 239.66 | 249.60 | 195.63 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.03 | -0.11 | -0.74 | -1.56 | -2.00 |
| Free Cash Flow Per Share | -0.03 | -0.11 | -0.74 | -1.56 | -2.01 |
| Dividend Paid and CapEx Coverage Ratio | -29.92 | -79.38 | -371.55 | -14.31 | -15.23 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | 0.00 | -2709587.00 | -509.40 |
| Operating Cash Flow Coverage Ratio | -0.03 | -0.09 | -0.28 | -0.69 | -0.99 |
| Operating Cash Flow to Sales Ratio | -0.04 | -0.17 | -0.55 | -1.41 | -1.98 |
| Free Cash Flow Yield | -11.16% | -32.52% | -52.06% | -56.07% | -14.73% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.15 | -0.62 | -0.91 | -1.29 | -3.54 |
| Price-to-Sales (P/S) Ratio | 0.40 | 0.53 | 1.07 | 2.51 | 13.49 |
| Price-to-Book (P/B) Ratio | -0.20 | -0.24 | -0.43 | -1.22 | -48.10 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -8.96 | -3.07 | -1.92 | -1.78 | -6.79 |
| Price-to-Operating Cash Flow Ratio | -8.96 | -3.07 | -1.92 | -1.78 | -6.80 |
| Price-to-Earnings Growth (PEG) Ratio | 0.03 | 0.01 | 0.03 | 0.03 | -0.07 |
| Enterprise Value Multiple | 13.65 | -10.28 | -4.04 | -2.68 | -5.74 |
| Enterprise Value | 33.36M | 33.04M | 35.95M | 43.14M | 106.46M |
| EV to EBITDA | 13.65 | -10.28 | -4.04 | -2.68 | -5.74 |
| EV to Sales | 2.09 | 2.40 | 2.98 | 4.48 | 13.92 |
| EV to Free Cash Flow | -46.40 | -13.88 | -5.37 | -3.18 | -7.01 |
| EV to Operating Cash Flow | -46.40 | -13.88 | -5.37 | -3.18 | -7.02 |
| Tangible Book Value Per Share | -1.21 | -1.39 | -3.33 | -2.29 | -0.28 |
| Shareholders’ Equity Per Share | -1.21 | -1.39 | -3.33 | -2.29 | -0.28 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.59 | 0.64 | 1.34 | 1.11 | 1.01 |
| Net Income Per Share | -0.09 | -0.39 | -1.57 | -2.15 | -3.85 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | -1.42 | 2.62 | 1.58 | 1.16 | 1.57 |
| Research & Development to Revenue | 0.17 | 0.16 | 0.21 | 0.34 | 0.36 |
| SG&A to Revenue | 0.53 | 0.79 | 1.21 | 1.83 | 2.43 |
| Stock-Based Compensation to Revenue | 0.00 | 0.11 | 0.09 | 0.07 | 0.12 |
| Income Quality | 0.30 | 0.28 | 0.47 | 0.73 | 0.52 |
Currency in USD

